An Extension Study of TAK-664 for Japanese People With Primary Immunodeficiency Disease

NCT04842643 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Takeda